Aaron Rosenberg, M.D., M.S.

Aaron Seth Rosenberg, M.D., M.S.



Bone Marrow Transplant

Internal Medicine



  • Assistant Professor, Department of Internal Medicine, Division of Hematology and Oncology


To see if Aaron Seth Rosenberg is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Comprehensive Cancer Center

4501 X Street, 2nd Floor
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Phone: 916-734-3771
Clinic Fax: 916-706-5265
Clinic Referral Phone: 916-703-5210
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Rosenberg's clinical interests include the diagnosis and care of multiple myeloma, and lymphoid malignancies, as well as the management of thrombosis. He is a member of the adult hematopoietic stem cell transplant team. 

Research/Academic Interests

Dr. Rosenberg focuses on outcomes research related to hematologic malignancies and thrombosis, as well as developing clinical trials for patients with hematologic malignancies. 


Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center


M.D., Mount Sinai School of Medicine, New York City, NY 2006

M.S., Sackler School of Biomedical Research, Boston MA 2014

B.A., Wesleyan university, Middletown CT 2001

Internship: Internal Medicine, Temple University Hospital, Philadelphia PA 2006-2007


Internal Medicine, Temple University Hospital, Philadelphia PA 2007-2009


Hematology/Oncology, Tufts - New England Medical Center, Boston MA 2010-2013

Board Certifications

American Board of Internal Medicine, 2009

American Board of Internal Medicine, Hematology, 2014

American Board of Medical Oncology,

Professional Memberships

American Medical Association

American Society of Clinical Oncology

American Society of Hematology

Select Recent Publications

Shah GL, Rosenberg AS, Jarboe J, Klein A, Cossor F. Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging. ScientificWorldJournal. 2014;2014:380814. Epub 2014 Oct 14.

Rosenberg A, Mathew P. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor. Expert Opin Investig Drugs. 2013 Jun;22(6):787-94. Epub 2013 Apr 1. Review.